{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:36:40Z","timestamp":1793111800497,"version":"4.5.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To compare sildenafil plus hydration with hydration alone in improving the amniotic fluid index and neonatal outcomes in pregnancies complicated by idiopathic oligohydramnios ( amniotic fluid index less than 5 cm without underlying maternal or fetal causes and with normal fetal growth).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This was an open-label randomized trial for women carrying singleton pregnancies at 30 weeks of gestation or more with idiopathic oligohydramnios detected during routine ultrasonogram. Women received either oral sildenafil citrate (25 mg every 8 hours) plus intravenous infusion of 2 L isotonic solution or fluids only until delivery. The primary study outcome was the amniotic fluid volume at 6 weeks of follow-up or the final volume before delivery, whichever occurred first. Secondary outcomes were duration of pregnancy prolongation, mode of delivery, and select neonatal outcomes. The study was powered to detect a 45% difference between groups, so, at an \u03b1 level of 0.05 and 80% power, a sample size of 167 women was required.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      From February 24, 2015, through April 2016, 196 women were screened and 184 were randomized. Follow-up was completed in 166 (90%): 82 in the sildenafil group and 84 in the hydration group. Baseline characteristics were similar between groups. The amniotic fluid volume was higher in the sildenafil group at the final assessment (11.5 compared with 5.4 cm,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.02). The sildenafil group delivered later (38.3 compared with 36.0 weeks of gestation,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.001), had a lower rate of cesarean delivery (28% compared with 73%), and their neonates were less likely to be admitted to the neonatal intensive care unit (11% compared with 41%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Sildenafil citrate increases amniotic fluid volume in pregnancies complicated by oligohydramnios.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, www.clinicaltrials.gov, NCT02372487.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000001928","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T07:29:37Z","timestamp":1489044577000},"page":"615-620","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":40,"title":["Sildenafil Citrate Therapy for Oligohydramnios"],"prefix":"10.1097","volume":"129","author":[{"given":"Mohammad Ahmed","family":"Maher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek Mohammad","family":"Sayyed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabih","family":"Elkhouly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261027","first-page":"183","article-title":"Oligohydramnios: problems and treatment","volume":"17","author":"McCurdy","year":"1993","journal-title":"Semin Perinatol"},{"key":"R2-20261027","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/sj.jp.7211290","article-title":"Amniotic fluid: not just fetal urine any more","volume":"25","author":"Underwood","year":"2005","journal-title":"J Perinatol"},{"key":"R3-20261027","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1210\/jc.2004-1831","article-title":"Sildenafil citrate (Viagra) enhances vasodilatation in fetal growth restriction","volume":"90","author":"Wareing","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-20261027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5505\/kjms.2011.32042","article-title":"The relation of intrapartum amniotic fluid index to perinatal outcomes","volume":"1","author":"\u00dclker","year":"2011","journal-title":"Kafkas J Med Sci"},{"key":"R5-20261027","first-page":"1098","article-title":"Maternal hydration increases amniotic fluid index","volume":"78","author":"Kilpatrick","year":"1991","journal-title":"Obstet Gynecol"},{"key":"R6-20261027","first-page":"525","article-title":"Effect of maternal hydration on oligohydramnios: a comparison of three volume expansion methods","volume":"92","author":"Doi","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R7-20261027","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00404-002-0346-z","article-title":"Duration of the increase in amniotic fluid index (AFI) after acute maternal hydration","volume":"269","author":"Malhotra","year":"2004","journal-title":"Arch Gynecol Obstet"},{"key":"R8-20261027","first-page":"685","article-title":"Is amniotic fluid influenced by a 24-hour fast?","volume":"45","author":"Wolman","year":"2000","journal-title":"J Reprod Med"},{"key":"R9-20261027","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1447-0756.2009.01043.x","article-title":"Oral hydration therapy in oligohydramnios","volume":"35","author":"Ghafarnejad","year":"2009","journal-title":"Obstet Gynaecol Res"},{"key":"R10-20261027","first-page":"743","article-title":"Decreased amniotic fluid index in low-risk pregnancy","volume":"46","author":"Kreiser","year":"2001","journal-title":"J Reprod Med"},{"key":"R11-20261027","first-page":"197","article-title":"Isolated oligohydramnios in the term pregnancy: is it a clinical entity?","volume":"7","author":"Conway","year":"1998","journal-title":"J Matern Fetal Med"},{"key":"R12-20261027","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0149-2918(01)80027-8","article-title":"Sildenafil citrate: a therapeutic update","volume":"23","author":"Boyce","year":"2001","journal-title":"Clin Ther"},{"key":"R13-20261027","doi-asserted-by":"crossref","first-page":"3C","DOI":"10.1016\/S0002-9149(99)00042-9","article-title":"Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro","volume":"83","author":"Wallis","year":"1999","journal-title":"Am J Cardiol"},{"key":"R14-20261027","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/01443610701194978","article-title":"A systematic review of experimental and clinical studies of sildenafil citrate for intrauterine growth restriction and pre-term labour","volume":"27","author":"Villanueva-Garc\u00eda","year":"2007","journal-title":"J Obstet Gynaecol"},{"key":"R15-20261027","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00006250-199406000-00011","article-title":"Correlation of measured amniotic fluid volume and sonographic predictions of oligohydramnios","volume":"83","author":"Horsager","year":"1994","journal-title":"Obstet Gynecol"}],"updated-by":[{"DOI":"10.1097\/aog.0000000000003429","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"record-id":"20950"},{"DOI":"10.1097\/aog.0000000000003836","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"record-id":"22856"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-201704000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:02:38Z","timestamp":1793109758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-201704000-00004"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000001928","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}